Total Payments
$287,299
2024 Payments
$28,905
Companies
81
Transactions
1,858
Medicare Patients
3,003
Medicare Billing
$3.4M
Payment Breakdown by Category
Other$180,250 (62.7%)
Consulting$40,000 (13.9%)
Food & Beverage$32,116 (11.2%)
Research$19,072 (6.6%)
Travel$15,437 (5.4%)
Education$424.23 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $178,950 | 108 | 62.3% |
| Consulting Fee | $40,000 | 8 | 13.9% |
| Food and Beverage | $32,116 | 1,649 | 11.2% |
| Unspecified | $19,072 | 2 | 6.6% |
| Travel and Lodging | $15,437 | 72 | 5.4% |
| Honoraria | $1,300 | 1 | 0.5% |
| Education | $424.23 | 18 | 0.1% |
Payments by Type
General
$268,227
1,856 transactions
Research
$19,072
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $119,608 | 199 | $0 (2022) |
| Biogen, Inc. | $51,298 | 175 | $0 (2024) |
| Eli Lilly and Company | $19,072 | 2 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $19,032 | 42 | $0 (2021) |
| ARGENX US, INC. | $14,014 | 32 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $10,738 | 71 | $0 (2024) |
| EMD Serono, Inc. | $9,021 | 43 | $0 (2023) |
| Allergan, Inc. | $8,403 | 68 | $0 (2022) |
| GENZYME CORPORATION | $7,315 | 50 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,826 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,905 | 240 | ARGENX US, INC. ($13,871) |
| 2023 | $4,181 | 215 | Amylyx Pharmaceuticals, Inc. ($400.02) |
| 2022 | $8,123 | 218 | Biohaven Pharmaceutical Holding Company Ltd. ($4,826) |
| 2021 | $30,846 | 217 | Biohaven Pharmaceuticals, Inc. ($19,032) |
| 2020 | $24,468 | 161 | Eli Lilly and Company ($13,156) |
| 2019 | $56,683 | 233 | Avanir Pharmaceuticals, Inc. ($25,059) |
| 2018 | $63,522 | 247 | Avanir Pharmaceuticals, Inc. ($40,573) |
| 2017 | $70,572 | 327 | Avanir Pharmaceuticals, Inc. ($52,311) |
All Payment Transactions
1,858 individual payment records from CMS Open Payments — Page 1 of 75
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Analgesic | ||||||
| 12/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Neurology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: PAIN | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $39.92 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $1,300.00 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/01/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Immunology and Neurology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $183.33 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $46.14 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | Eli Lilly and Company | $19,072 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 702 | 26,709 | $3.1M | $947,773 |
| 2022 | 15 | 804 | 27,667 | $3.2M | $984,521 |
| 2021 | 11 | 690 | 20,661 | $2.4M | $757,266 |
| 2020 | 15 | 807 | 20,452 | $2.4M | $693,757 |
Total Patients
3,003
Total Services
95,489
Medicare Billing
$3.4M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 22 | 24,940 | $2.8M | $835,321 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 614 | $104,994 | $48,143 | 45.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 28 | 384 | $80,640 | $17,495 | 21.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 93 | 142 | $20,164 | $9,126 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $20,174 | $8,970 | 44.5% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 22 | 370 | $40,700 | $5,513 | 13.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 18 | 18 | $10,350 | $4,931 | 47.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 11 | 11 | $8,250 | $3,492 | 42.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 25 | 25 | $7,475 | $3,183 | 42.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 31 | 31 | $7,037 | $2,986 | 42.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 17 | 18 | $6,516 | $2,388 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $3,450 | $1,869 | 54.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $3,597 | $1,616 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $2,975 | $1,529 | 51.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 28 | 28 | $2,492 | $1,210 | 48.6% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 23 | 21,700 | $2.4M | $717,433 | 29.4% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 15 | 4,120 | $463,500 | $151,708 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 264 | 504 | $86,184 | $42,284 | 49.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 31 | 416 | $87,360 | $20,031 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 91 | 91 | $24,022 | $10,072 | 41.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 94 | 137 | $19,454 | $9,812 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 159 | $18,961 | $8,342 | 44.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 24 | 393 | $43,230 | $6,113 | 14.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 28 | 28 | $11,900 | $5,125 | 43.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 14 | 14 | $6,888 | $3,053 | 44.3% |
About Dr. Nathaniel Whaley, MD
Dr. Nathaniel Whaley, MD is a Neurology healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245213545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathaniel Whaley, MD has received a total of $287,299 in payments from pharmaceutical and medical device companies, with $28,905 received in 2024. These payments were reported across 1,858 transactions from 81 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($178,950).
As a Medicare-enrolled provider, Whaley has provided services to 3,003 Medicare beneficiaries, totaling 95,489 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Johnson City, TN
- Active Since 11/22/2005
- Last Updated 03/08/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1245213545
Products in Payments
- NUEDEXTA (Drug) $111,299
- TECFIDERA (Drug) $26,352
- NURTEC ODT (Drug) $24,114
- TYSABRI (Biological) $14,782
- ULTOMIRIS (Biological) $9,987
- ONZETRA Xsail (Drug) $8,390
- UBRELVY (Drug) $8,267
- VYVGART HYTRULO (Drug) $7,757
- AUBAGIO (Drug) $6,816
- VYVGART (Drug) $6,210
- Mavenclad (Biological) $5,269
- Rebif (Biological) $3,550
- OCREVUS (Biological) $2,709
- VYEPTI (Biological) $1,930
- KESIMPTA (Drug) $919.58
- Briviact (Drug) $900.20
- Fycompa (Drug) $891.97
- VALTOCO (Drug) $822.55
- NUPLAZID (Drug) $812.73
- TROKENDI XR (Drug) $689.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Johnson City
Shamaelah Javed
Neurology — Payments: $6,134
Neurology $6,134
Mr. Tanzid Shams, M.d, M.D
Neurology — Payments: $5,664
Neurology $5,664
Yahia Lodi, M.d, M.D
Neurology — Payments: $5,001
Neurology $5,001
Mr. Stephen Kimbrough, Md, MD
Neurology — Payments: $4,632
Neurology $4,632
Amrinder Singh, Md, MD
Neurology — Payments: $4,102
Neurology $4,102
Dr. Stafford Conway, Md, MD
Neurology — Payments: $2,451
Neurology $2,451